Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» As Humira readies for biosimilar rivals, AbbVie looks to ASH to build oncology momentum
As Humira readies for biosimilar rivals, AbbVie looks to ASH to build oncology momentum
As Humira readies for biosimilar rivals, AbbVie looks to ASH to build oncology momentum
Submitted by
admin
on December 3, 2016 - 9:21am
Source:
Fierce Pharma
News Tags:
Humira
AbbVie
biosimilars
ASH
Headline:
As Humira readies for biosimilar rivals, AbbVie looks to ASH to build oncology momentum
Do Not Allow Advertisers to Use My Personal information
